Gemcitabine-based combination therapy compared with gemcitabine alone for advanced pancreatic cancer: a meta-analysis of nine randomized controlled trials-Reference-Cited by-同舟云学术

Gemcitabine-based combination therapy compared with gemcitabine alone for advanced pancreatic cancer: a meta-analysis of nine randomized controlled trials

Published:2017-06 Issue:3 Volume:16 Page:236-244
ISSN:1499-3872
Container-title:Hepatobiliary & Pancreatic Diseases International
language:en
Short-container-title:Hepatobiliary & Pancreatic Diseases International

Author:

Jin Shui-Fang,Fan Zhao-Kun,Pan Lei,Jin Li-Ming

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference29 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

2. European cancer mortality predictions for the year 2013;Malvezzi;Ann Oncol,2013

3. Cancer statistics, 2014;Siegel;CA Cancer J Clin,2014

4. Pancreatic cancer;Kamisawa;Lancet,2016

5. Chemotherapy in pancreatic adenocarcinoma;Squadroni;Eur Rev Med Pharmacol Sci,2010

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant gemcitabine after resection of pancreatic cancer without significant difference in overall survival: a retrospective cohort study;Annals of Medicine & Surgery;2023-05-20

2. Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study;MedComm;2023-02-19

3. Combined chemotherapy based on bioactive black phosphorus for pancreatic cancer therapy;Journal of Controlled Release;2023-02

4. Survival benefits and safety of chemotherapy regimens for pancreatic cancer: An umbrella review of meta-analyses of randomized controlled trials;Annals of Pancreatic Disorders and Treatment;2022-06-03

5. Two Possible Strategies for Drug Modification of Gemcitabine and Future Contributions to Personalized Medicine;Molecules;2022-01-04